We are live on ! Find out more
BNTCW

Benitec Biopharma Limited
BNTCW

Delisted

BNTCW was delisted on the 14th of April, 2020.

Back to rankings

1 hedge funds and large institutions have $2K invested in Benitec Biopharma Limited in 2020 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

50% less capital invested

Capital invested by funds: $4K → $2K (-$2K)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CH
1
CVI Holdings
Delaware
$2K – – –

BNTCW Hedge Fund Activity: Q1 2020 in Review

1 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Benitec Biopharma Limited (BNTCW) for Q1 2020, worth a combined $2K — down 50% from $4K a quarter earlier.

Fund positioning in BNTCW was balanced in Q1 2020: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Benitec Biopharma Limited (BNTCW) as of Q1 2020, unchanged from Q4 2019.
  • Funds reported $2K of Benitec Biopharma Limited stock for Q1 2020, down 50% quarter-over-quarter.
  • 0 funds opened new Benitec Biopharma Limited positions in Q1 2020 and 0 closed out.

Based on aggregated 13F filings for Q1 2020.